Moberg Pharma reports new Phase 3 analyses on terbinafine activity in onychomycosis
GE HealthCare to acquire SOFIE Biosciences for USD945m
Ractigen Therapeutics reports positive first-in-human data for RAG-18 in Duchenne muscular dystrophy
AnnJi Pharmaceutical's AJ201 advances into pivotal Phase 3 trial for SBMA
Teva reports new ecopipam data showing tic reduction in Tourette syndrome
Johnson & Johnson reports two-year ICOTYDE data showing sustained clearance in high-impact psoriasis
Clear Scientific reports positive CS-1103 Phase 2 Results in removing fentanyl from the Body
Avimer Bio and CNIO publish JACS study on computational design of self‑assembling protein cages
MHRA approves Zepzelca and atezolizumab as first-line maintenance therapy for ES-SCLC in the UK
Pfizer's tilrekimig shows significant skin clearance in Phase 2 atopic dermatitis study
Sanofi and Regeneron expand antibody alliance with four next-generation immunology programmes
AFYREN ingredient enables global launch of natural propionic acid skincare product
Fresenius acquires remaining stake in mAbxience
Lilly reports positive 48-week Phase 2b resu;ts for EloraTZP